Protein tyrosine phosphorylation is a dynamic reversible process in which the level of phosphorylation, at any point, is the result of phosphatase and/or kinase activity. This balance is critical for control of growth and differentiation. The role of tyrosine phosphatases during nephrogenesis and in kidney disease requires delineation. Appropriate regulation of focal adhesion proteins such as focal adhesion kinase (FAK) and paxillin are important in cell adhesion, migration and differentiation. We have previously shown that bcl-2 -/-mice develop cystic kidneys and exhibit sustained phosphorylation of FAK and paxillin. Here we have examined the expression and activity of focal adhesion tyrosine phosphatases SHP-2, PTP1B and PTP-PEST during normal nephrogenesis and in cystic kidneys from bcl-2 -/-mice. Cystic kidneys from P20 bcl-2 -/-mice demonstrate a reduced expression, a 6-fold decrease in activity and altered distribution of SHP-2 and PTP1B. PTP-PEST expression and distribution were similar in both bcl-2 +/+ and bcl-2 -/-mice. The altered regulation of PTP1B and SHP-2 in kidneys from bcl-2 -/-mice correlates with sustained phosphorylation of FAK and paxillin.
INTRODUCTION
Renal hypoplasia/dysplasia/aplasia are the second leading cause for renal transplantation in children. These renal diseases are the result of abnormal development due to altered growth, differentiation and/or organogenesis (29). Bcl-2 is a death repressor that plays an important role during nephrogenesis. Mice deficient in bcl-2 (bcl-2 -/-) develop renal hypoplasia/cystic dysplasia. Renal cyst formation in bcl-2 -/-mice, as well as other renal cystic diseases, is characterized by increases in apoptosis and proliferation, altered tubular morphology and epithelial cells that do not fully differentiate (3, 4, 13, 23, 30, 31) . Gross cyst formation in bcl-2 -/-mice occurs at multiple sites along the nephron at postnatal day 20 (P20) (25) . We have observed nuclear localization of β-catenin, loss of apical brush border actin staining and sustained phosphorylation of focal adhesion kinase (FAK) and paxillin in cystic kidneys from bcl-2 -/-mice suggesting that altered cell adhesive mechanisms occur (24, 26) . Interestingly, renal cyst formation in these mice occurs at a time when bcl-2 expression normally has declined significantly. This suggests that loss of bcl-2 early during nephrogenesis may affect the ability of these kidneys to differentiate/mature at later times.
Tyrosine phosphatases play an important role during growth and differentiation. Altered regulation of tyrosine phosphatases may contribute to aberrant protein phosphorylation leading to disease. The role these phosphatases play during nephrogenesis and renal cyst formation is unknown.
We have recently demonstrated that FAK and paxillin are highly expressed and phosphorylated during normal nephrogenesis and decline to very low levels following renal maturation (postnatal day 20;P20)(26). In contrast, sustained phosphorylation of FAK and paxillin was observed in cystic kidneys from P20 bcl-2 -/-mice. The overexpression of phosphorylated FAK or paxillin, in myoblasts, causes these cells to remain proliferative and inhibits their ability to initiate terminal differentiation (20) thus, it is tempting to speculate that this occurs in cystic kidneys from the bcl-2 -/-mice. Therefore, dephosphorylation of FAK and paxillin may play an important role during differentiation F-0184-2001.R1 and renal maturation.
SHP-2, PTP-PEST and/or PTP1B can dephosphorylate focal adhesion proteins, such as FAK and paxillin impacting cell growth and differentiation. Cells that lack expression of these phosphatases have hyperphosphorylation of FAK and paxillin as well as altered adhesion and migratory properties (2, 34) . Cultured fibroblasts lacking functional SHP-2 have a reduced ability to spread and migrate on fibronectin, increased number of focal adhesions, condensed F-actin aggregation at the cell periphery and a significant reduction in FAK dephosphorylation (34). Cytoskeletal organization is altered in these SHP-2 mutant cells, similar to FAK-deficient cells. Cells deficient in PTP-PEST also have a phenotype similar to FAK deficient cells with altered cell migration and decreased turnover of focal adhesions. PTP-PEST acts to potentiate the action of FAK rather than antagonize it (2) . These data suggest tyrosine phosphatases such as SHP-2 and PTP-PEST may work together with FAK to control the dynamics of focal adhesions (2, 34) . Overexpression of PTP1B in fibroblasts decreased cell migration, increased the time for cell spreading and leads to formation of large focal complexes scattered over the ventral surface, similar to that observed in PTP-PEST deficient cells. Therefore, it is thought that an intermediate level of tyrosine phosphatase activity is necessary for formation of normal focal adhesions and cell migration (2) .
In order to gain insight into the role SHP-2, PTP1B and PTP-PEST play during nephrogenesis and renal cyst formation, we have examined their expression, distribution and activity in normal and cystic kidneys. Cystic kidneys from bcl-2 -/-mice displayed reduced expression and activity as well as an altered distribution of SHP-2 and PTP1B. SHP-1 and PTP-PEST expression were not affected in these kidneys. Thus, inappropriate expression and activation of tyrosine phosphatases SHP-2 and PTP1B may impede terminal differentiation of renal epithelial cells contributing to renal cyst formation. 
MATERIALS AND METHODS
Animal Breeding: Bcl-2 heterozygote animals were interbred. The genotypes of the offspring were determined by PCR analysis as previously described (26). To examine expression of SHP-2, SHP-1, PTP-1B and PTP-PEST normal mice were interbred and the kidneys were removed at the times noted. Embryos were removed from anesthetized pregnant female mice on day 15 of pregnancy.
Kidneys were surgically dissected from embryos and postnatal mice. Samples from affected cpk/cpk mice and their normal littermates were generously supplied by Dr. James Calvet. Immunoprecipitation and Phosphatase Assays. Kidneys were homogenized and sonicated in
Protein Lysate Preparation and
The protein concentration was determined and 600 µg of total protein was incubated with 3 µg of anti- overnight with the primary antibody and processed as previously described (25) . The slides were then photographed. thus, modulating cell adhesion and migration (18) . We examined SHP-2 expression in kidneys from E15, P0, P10 and P20 mice to delineate expression during normal nephrogenesis and following renal maturation (at P20). In addition, we examined SHP-2 expression in cystic kidneys from P20 in bcl-2 -/-mice. Gross cyst formation occurs at multiple sites along the nephron, at P20 (25).
Phosphorylated p70 SHP-2 was highly expressed during normal nephrogenesis. In the normal kidney, dephosphorylated (p64) SHP-2 was virtually undetectable at E15 and P0. We first observed expression of p64 SHP-2 at P10, when renal maturation nears completion ( Figure 1 ). Following renal maturation (P20), in kidneys from bcl-2 +/+ mice, there were significant amounts of both the phosphorylated (p70) and unphosphorylated (p64) SHP-2 ( Figure 1 ). In contrast, p64 SHP-2 expression in kidney lysates from P20 bcl-2 -/-mice was low, similar to expression in normal P10 kidney lysates.
To determine the catalytic activity of SHP-2, kidney lysates from P20 bcl-2 +/+, bcl-2 -/-and P10 bcl-2 +/+ mice were immunoprecipitated with anti-SHP-2 and the catalytic activity determined, as described in Materials and Methods. The reactions were linear over the time assayed. SHP-2 released 1408 ± 9 pmol of phosphate per mg of total protein from kidney lysates from P20 bcl-2 +/+ mice, 225
± 3 pmol of phosphate per mg of total protein from P20 bcl-2 -/-mice, 165±4 pmol of phosphate per mg of total protein from P10 bcl-2 +/+ mice and 100 ± 3 pmol of phosphate per mg protein from
lysates immunoprecipitated with IgG (negative control). Figure 2 is a graphic representation of the data demonstrating a 6.3-fold decrease in SHP-2 activity in kidney lysates from P20 bcl-2 -/-mice compared to bcl-2 +/+ mice.
We have examined the distribution of SHP-2 in kidneys from P20 bcl-2 +/+ (following renal maturation) and P20 bcl-2 -/-mice (when significant cyst formation is observed). Nephron segments were identified by lectin staining and morphology. Kidneys from bcl-2 +/+ mice display intense SHP-2 staining on the cell periphery in inner medullary collecting ducts (Figure 3 G) . No staining was observed in cortical or outer medullary collecting ducts (data not shown). In the cortex of the normal kidney, staining was observed in glomeruli (arrow: Figure 3A ), distal tubules and proximal tubules ( Figure 3A ). In proximal tubules intense staining was noted on the apical membrane (arrowhead: Figure 3A ). An altered distribution was observed in cystic kidneys from bcl-2 -/-mice. Kidneys from these mice displayed reduced staining in glomeruli (arrow: Figure 3B ), loss of staining in cystic proximal tubules ( Figure 3C : arrow to apical membrane of cystic tubule) and reduced staining of the apical membrane of non-cystic proximal tubules (arrowhead: Figure 3B ). Kidneys from bcl-2 -/-mice display intense SHP-2 staining in inner medullary collecting ducts similar to that observed in bcl-2 +/+ mice ( Figure 3H ). Together these results demonstrate that SHP-2 activity, expression and distribution are altered in cystic kidneys from bcl-2 -/-mice.
Expression of a closely related tyrosine phosphatase SHP-1 is not affected. SHP-1 is a
non-transmembrane tyrosine phosphatase with significant sequence identity to SHP-2 (16,33).
However, the two phosphatases have distinct biological roles (27). We have examined the expression of SHP-1 during nephrogenesis and in cystic kidneys from P20 bcl-2 -/-mice. SHP-1 was expressed at similar levels during nephrogenesis and in normal and cystic kidneys ( Figure 4 ). Since SHP-1 is constitutively expressed during nephrogenesis and SHP-2 expression increases following renal maturation, in the normal kidney, these tyrosine phosphatases may have different functions during
nephrogenesis.
PTP 1B expression and activity is altered in cystic kidneys from bcl-2 -/-mice. PTP 1B is a 50 kDa tyrosine phosphatase that can be cleaved by calpain to a more catalytically active 42 kDa form (10) . Both the 42 and 50 kDa forms of PTP1B are expressed in the kidney ( Figure 5 ). P50
PTP1B was highly expressed in kidneys from E15, P0 and P10 normal mice. Only a low level of p42 PTP1B expression was observed in these lysates ( Figure 5 ). In kidneys from bcl-2 +/+ mice, expression of 50kDa PTP1B declined at renal maturation (P20) with a concomitant increase in 42 kDa PTP1B expression ( Figure 5 ). In contrast, in kidney lysates from P20 bcl-2 -/-mice expression of PTP1B remained low, similar to that observed in kidneys from normal P10 mice ( Figure 5 ).
We next determined the activity of PTP1B in kidney lysates from P20 bcl-2 +/+, P20 bcl-2 -/-and P10 bcl-2 +/+ mice. Lysates were immunoprecipitated with anti-PTP1B and the phosphatase activity of the immunoprecipitates was determined. PTP 1B released 1242 ± 10 pmol of phosphate per mg of total protein in kidney lysates from P20 bcl-2 +/+ mice, 225 ± 4 pmol of phosphate from P20
bcl-2 -/-mice, 830±8 pmol of phosphate from P10 bcl-2 +/+ mice and 115 ± 3 pmol of phosphate from lysates immunoprecipitated with IgG (negative control). A graphic representation of the data, shown in Figure 6 , demonstrates a 5.5-fold decrease in PTP1B activity in kidney lysates from P20 bcl-2 -/-mice compared to P20 bcl-2 +/+ mice. Therefore, kidneys from P20 bcl-2 -/-mice displayed a decreased expression of 42 kDa PTP1B and decreased PTP1B activity compared to their normal littermates.
The distribution of PTP1B was examined in kidneys from P20 bcl-2 +/+ and bcl-2 -/-mice. In the normal adult kidney, PTP1B was detected in distal tubules, collecting ducts, and glomeruli.
Staining in distal tubules (arrow: Figure 7A ) and cortical ( Figure 7C ) and medullary collecting ducts was observed on the cell periphery. Faint staining was also observed in proximal tubules ( Figure 7A ).
In contrast, cystic tubules in kidneys from bcl-2 -/-mice displayed altered localization and/or loss of PTP1B expression. Figure 7 demonstrates that cystic medullary collecting ducts (arrowhead: Figure 7 F-0184-2001.R1
F) lose PTP1B expression compared to non-cystic collecting ducts (arrow: Figure 7F ) in kidneys from bcl-2 -/-mice. In addition in these kidneys, cystic distal tubules lose PTP1B expression on the cell periphery and instead display apical brush border PTP1B staining (arrow head points to apical membrane: Figure 7E ). Non-cystic distal tubules in these kidneys have distribution of PTP1B similar to that observed in bcl-2 +/+ mice (arrow: Figure 7E ).
PTP-PEST expression is not affected in kidneys from bcl-2 -/-mice. PTP-PEST is a tyrosine phosphatase also involved in regulating tyrosine phosphorylation of focal adhesion proteins.
PTP-PEST binds signaling molecules including Csk (8), paxillin (22) , Shc (5, 14) , and Grb2(6) in its non-catalytic region. PTP-PEST is a 120kDa protein that was highly expressed in kidney lysates from E15 normal mice ( Figure 8 ). Expression of p120 PTP-PEST was observed at P0, but declined to very low levels at later postnatal times in these mice. The decline of p120 PTP-PEST occurred together with an increase in a 73 kDa protein (p73 PTP-PEST) during postnatal renal maturation. Expression of p120 and p73 PTP-PEST were similar in kidneys from P20 bcl-2 +/+ and bcl-2 -/-mice ( Figure 8 ).
The distribution of PTP-PEST was examined in kidneys from P20 bcl-2 +/+ and bcl-2 -/-mice.
We observed a similar distribution of PTP-PEST in kidneys from bcl-2 +/+ and bcl-2 -/-mice. PTP-PEST was expressed in glomeruli, distal tubules, collecting ducts, thick ascending limb and proximal tubules ( Figure 9A and B). We observed intense glomerular staining and focused staining on the apical surface of distal tubules (arrow: Figure 9A ). In addition, proximal tubules display PTP-PEST staining with nuclear staining observed particularly in the S2 and S3 segments (arrowhead: Figure 9A and B).
SHP-2 and PTP1B expression is altered in cystic kidneys from cpk mice. Affected cpk/cpk mice have polycystic kidney disease that is similar to autosomal-recessive polycystic kidney disease in humans (11, 15) . Proximal tubules begin to dilate in embryonic and newborn animals with the kidneys of the affected animals becoming grossly cystic during the first three weeks of life. To determine whether the decreased expression of SHP-2 and PTP1B was unique to cystic kidneys from bcl-2 -/-
mice we examined their expression in cystic kidneys from the affected cpk/cpk and normal littermates.
We observed decreased expression of both of these phosphatases in cystic kidneys from P20 bcl-2 -/-mice ( Figures 1 and 5 ). Figure 10 demonstrates Western analysis of protein lysates prepared from affected P20 cpk/cpk (CY) and P20 normal littermates (NL) blotted for SHP-2 (A) and PTP1B (B).
We observed decreased expression of both SHP-2 and the 42 kDa PTP1B expression in lysates from the affected cpk/cpk mice compared to the normal littermates. The blots were stripped and reblotted with β-catenin to control for loading. We had previously observed that the expression of β-catenin is similar throughout nephrogenesis and in cystic kidneys (26). Similar expression of β-catenin was observed in cpk/cpk and normal littermates (data not shown). Cystic kidneys have increased amounts of apoptosis and proliferation suggesting that epithelial differentiation is not complete (3,4,9,12,25,31). These changes occur in the bcl-2 -/-mouse at a time when bcl-2 expression is normally low, suggesting that its loss early in development may alter signaling pathways which ultimately result in the inability of these epithelial cells to terminally differentiate. In P20 bcl-2 -/-mice, renal cystic disease correlated with sustained phosphorylation of p125 FAK and p68 paxillin although no changes in the levels of these proteins were observed (26).
Since the overexpression of phosphorylated FAK or paxillin, in myoblasts, causes these cells to remain proliferative and inhibits their ability to initiate terminal differentiation (20) it is tempting to speculate that this occurs in cystic kidneys from the bcl-2 -/-mice. Our previous studies, as well as studies from others, indicate that down-regulation of FAK and paxillin phosphorylation is essential for stabilization of focal adhesion complexes and promotion of a non-proliferative differentiated phenotype (20, 26) . This is perhaps mediated, at least in part, through local recruitment and activation of focal adhesion
tyrosine phosphatases. Therefore, appropriate dephosphorylation of these proteins may be required during nephrogenesis.
SHP-2 is a widely expressed cytosolic tyrosine phosphatase that plays a role in growth factor and integrin mediated signaling pathways. SHP-2 can interact with various signaling molecules through its SH2 domains. It is recruited to focal adhesions and can modulate the activity of FAK (18) .
The loss of functional SHP-2 is lethal midgestation, with a phenotype similar to FAK and fibronectindeficient embryos due to important migratory defects (21) . The SHP-2 mutation also suppresses erythroid and myeloid differentiation suggesting an important role during hematopoietic development (19) . In addition, loss of functional SHP-2 in embryonic stem cells inhibits epithelial and fibroblast differentiation in vitro (19) . Therefore, SHP-2 may positively mediate cell differentiation. In the studies presented here, expression and activity of SHP-2 were reduced in kidneys from bcl-2 -/-mice compared to their wild-type littermates. SHP-2 expression was also reduced in kidneys from the cpk/cpk mice. This would be consistent with epithelial cells from kidneys of P20 bcl-2 -/-and cpk/cpk mice, which express substantially lower amounts of SHP-2, being unable to fully differentiate. This altered expression appears to be specific for SHP-2 since SHP-1, a non-transmembrane tyrosine phosphatase with significant sequence identity to SHP-2 (16,33), is not affected. These two phosphatases have distinct biological roles (27) which is apparent in these studies. Thus, appropriate expression and activation of SHP-2 may be essential during normal nephrogenesis.
PTP1B is a 50 kDa protein that has an ubiquitous tissue distribution. PTP1B is cleaved by calpain to a more catalytically active 42 kDa protein (10) . Introduction of wild-type PTP1B into 3Y1 fibroblasts reduces phosphorylation of FAK and the rate of cell spreading (17) . In addition, expression of dominant negative PTP1B results in a reduction of adhesion and spreading on fibronectin (1) .
Esophageal cancers also demonstrate a significant reduction of PTP1B expression compared to surrounding tissue (28). The data presented here demonstrate a decrease in p42 PTP1B expression and
PTP1B activity, as well as an altered distribution in cystic kidneys from P20 bcl-2 -/-mice compared to bcl-2 +/+ mice, thus suggesting a role for PTP1B during renal maturation. We also observed decreased expression of 42 kDa PTP1B in cpk/cpk kidneys. Together these data indicate that altered expression of SHP-2 and PTP1B may contribute to an immature cystic phenotype.
Tyrosine phosphatases localize to focal adhesion complexes are important in modulation of FAK activity during cell adhesion and migration. We believe that during the final stages of renal maturation, when down-regulation of FAK and paxillin should occur, SHP-2 and PTP1B are not properly recruited to focal adhesion complexes and/or activated. This hypothesis is supported by our data demonstrating decreased expression and activity and altered localization of PTP1B in cystic kidneys. For example in the normal kidney, PTP1B localizes to the basolateral membrane where FAK and paxillin are expressed (26). However, in cystic distal tubules PTP1B is misdirected to the apical membrane. Thus, in cystic distal tubules PTP1B may not have access to FAK and paxillin to dephosphorylate them.
PTP-PEST is a cytoplasmic tyrosine phosphatase that can modulate focal adhesion complexes.
It has a N-terminal catalytic domain and a C-terminal domain containing several PEST (proline, glutamate, serine and threonine) sequences (8, 22) . Fibroblasts lacking PTP-PEST have decreased migration, increased numbers of focal adhesions and hyperphosphorylation of FAK and paxillin (7).
We observed similar levels and distribution of PTP-PEST in kidneys from P20 bcl-2 -/-and bcl-2 +/+ mice. At P20, p73 PTP-PEST is the most abundant form, recognized with an antibody against the noncatalytic domain. Thus, PTP-PEST expression is similar in kidneys from bcl-2 +/+ and bcl-2 -/-mice.
In summary, the appropriate recruitment and activation of tyrosine phosphatases to focal adhesion complexes are essential for stabilization of cellular adhesive mechanisms and modulation of cell adhesion and migration. The decreased activity and expression, as well as an altered distribution of PTP 1B and SHP-2 are consistent with sustained phosphorylation of FAK and paxillin and the
immature/undifferentiated cystic phenotype in bcl-2 -/-mice. Our data demonstrating that SHP-2 and PTP1B expression is reduced in cystic kidneys from the cpk mice suggest that these changes are not unique to the bcl-2 -/-mouse. Thus, proper regulation of tyrosine phosphatases, including SHP-2 and PTP1B, may play an important role during renal maturation.
development and cystogenesis in the bcl-2 -/-mouse. 
